
51 - 200 funcionários
🏥 Saúde
🍽️ Alimentos e Bebidas
🧬 Biotecnologia
💰 $30.000.000 Post-IPO Secondary - DBV Technologies em 2025-10
Healthcare • Food & Beverage • Biotechnology
A DBV Technologies é uma empresa biofarmacêutica global em estágio clínico que desenvolve imunoterapia epicutânea para tratar alergias alimentares e outras doenças mediadas pelo sistema imunológico. Fundada por pediatras, a empresa está avançando sua tecnologia proprietária de adesivo VIASKIN® através de ensaios clínicos — incluindo estudos de Fase 3 para um adesivo para alergia a amendoim (DBV712) e programas em estágios iniciais para alergia ao leite (DBV135) — com o objetivo de reeducar o sistema imunológico usando a exposição controlada da pele a antígenos.
🕒 Julho 21
🏖️ New Jersey – Remoto
💵 $200.000 - $240.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
👻 Score fantasma 22%
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
🏥 Saúde
🍽️ Alimentos e Bebidas
🧬 Biotecnologia
💰 $30.000.000 Post-IPO Secondary - DBV Technologies em 2025-10
Healthcare • Food & Beverage • Biotechnology
A DBV Technologies é uma empresa biofarmacêutica global em estágio clínico que desenvolve imunoterapia epicutânea para tratar alergias alimentares e outras doenças mediadas pelo sistema imunológico. Fundada por pediatras, a empresa está avançando sua tecnologia proprietária de adesivo VIASKIN® através de ensaios clínicos — incluindo estudos de Fase 3 para um adesivo para alergia a amendoim (DBV712) e programas em estágios iniciais para alergia ao leite (DBV135) — com o objetivo de reeducar o sistema imunológico usando a exposição controlada da pele a antígenos.
• Serve as a scientific expert and key point of contact between DBV Technologies and external payer and population health decision-makers • Communicate evidence-based information on VIASKIN Peanut’s value proposition and pediatric food allergy health outcomes • Engage national and regional payers, PBMs, IDNs, employers, and population health key opinion leaders • Communicate efficacy, safety, patch wear-time, and real-world relevance to support coverage and formulary decisions • Conduct educational programs, scientific presentations, and value-evidence discussions • Establish and maintain relationships with medical and pharmacy directors, payer decision-makers, professional societies, and patient advocacy organizations • Disseminate health outcomes data, real-world evidence, health economic models, and budget-impact analyses • Collaborate with Market Access, Medical Affairs, Value & Access, Commercial, and Field Reimbursement teams • Design outcomes-based analytics using internal data sources and external vendors such as IQVIA, Optum Insights, and Komodo • Train internal teams on outcomes data and value evidence • Address unsolicited payer inquiries in accordance with regulations and company policy • Support investigator-initiated studies, real-world evidence generation, and other research initiatives • Contribute to strategic plans for health outcomes research, value-evidence communication, and payer engagement • Integrate health outcomes strategies into product launch, access, and commercialization plans • Ensure communications and interactions comply with regulatory requirements, legal guidance, and company policies
• PharmD, M.D., or Ph.D. in a health sciences–related field required • Master’s in pharmacoepidemiology, epidemiology, or health economics preferred • Minimum of eight (8) years working in the pharmaceutical, biotechnology, or healthcare industry • Minimum of five (5) years in a HEOR or payer-facing scientific function supporting product launches with U.S. Market Access teams • Experience spanning medical and scientific affairs, outcomes research, clinical practice, academic, or U.S. managed-markets settings • Therapeutic experience in allergy/immunology, pediatrics, and/or rare disease preferred; familiarity with the food allergy treatment landscape is a strong advantage • Strong understanding of health outcomes research, epidemiology, and health economics • Demonstrated experience engaging national and regional payers, PBMs, IDNs, and other organized customers in a scientific or value-evidence capacity • Expertise in economic modeling, budget-impact analysis, data analysis, and interpreting clinical and real-world data • Knowledge of industry trends, healthcare policies, and regulations impacting HEOR • Understanding of therapeutic areas, disease mechanisms, treatment landscapes, and market dynamics • Excellent written, verbal, communication, and presentation skills • Strong proficiency with regulatory guidelines and requirements related to HEOR studies and payer scientific exchange • Understanding of compliance and ethical considerations in research and payer engagement • Ability to build relationships with external stakeholders, thought leaders, and academic HEOR experts • Ability to collaborate cross-functionally, manage multiple projects, prioritize tasks, meet deadlines, and adapt to changing priorities • Proficiency in resource allocation, budget management, and project planning • Comfort operating in an ambiguous, fast-paced, pre-commercial environment • Ability to articulate clearly and conduct presentations with large and small audiences
Candidatar-se🕒 Julho 21
HEOR Director managing strategic healthcare quality and evidence generation for Boehringer Ingelheim products. Overseeing cross-functional collaboration and leading the HEOR strategy for multiple therapeutic areas.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $200.000 - $316.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 21
Director of HEOR responsible for leading healthcare quality strategies in obesity and liver disease. Collaborating across functions to support brand value propositions in the US market.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $200.000 - $316.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 20
Executive Director responsible for leading digital infrastructure and AI capabilities for Vaxcyte’s commercial launch. Collaborating across functions to enhance commercial operations and effectiveness.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $288.000 - $335.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 20
Director managing health systems partnerships at Karius, specializing in infectious disease diagnostics through genomic technology. Building strategic relationships and driving system-wide adoption of the Karius Test.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $178.252 - $267.378 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 20
Director of Targeted Acquisition leading the scaling of AI-powered systems at Mercer Advisors. Focused on strategy, execution, and effective adoption of tools for high-value prospecting.
🗣️🇺🇸🇬🇧 Inglês obrigatório